Last reviewed · How we verify
P-3058 10%
P-3058 10% is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
P-3058 10% is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2). Used for Type 2 diabetes.
At a glance
| Generic name | P-3058 10% |
|---|---|
| Sponsor | Polichem S.A. |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
By inhibiting SGLT2, P-3058 10% reduces glucose reabsorption in the kidneys, leading to a decrease in blood glucose levels. This mechanism is particularly useful in the treatment of type 2 diabetes. Additionally, the inhibition of SGLT2 may also have a beneficial effect on blood pressure and body weight.
Approved indications
- Type 2 diabetes
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Hypotension
- Increased urination
Key clinical trials
- Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis (PHASE3)
- Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |